NCT00355472View on ClinicalTrials.gov

Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Adult T-Cell Leukemia and Lymphoma (ATL)Adult Peripheral T-Cell Lymphoma (PTCL)
Interventions
DRUG

KW-0761

IV administration at 4 escalating dose levels.

Trial Locations (1)

Unknown

Tokyo

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT00355472 - Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL | Biotech Hunter | Biotech Hunter